MX2018001239A - Amida seleccionada de acido gamma-hidroxibutirico y usos de la misma en el tratamiento de abuso de alcohol. - Google Patents
Amida seleccionada de acido gamma-hidroxibutirico y usos de la misma en el tratamiento de abuso de alcohol.Info
- Publication number
- MX2018001239A MX2018001239A MX2018001239A MX2018001239A MX2018001239A MX 2018001239 A MX2018001239 A MX 2018001239A MX 2018001239 A MX2018001239 A MX 2018001239A MX 2018001239 A MX2018001239 A MX 2018001239A MX 2018001239 A MX2018001239 A MX 2018001239A
- Authority
- MX
- Mexico
- Prior art keywords
- gamma
- hydroxybutyric acid
- treatment
- alcohol misuse
- selected amide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
La presente invención se relaciona con una amida seleccionada de ácido ?-hidroxibutírico, un proceso de elaboración y usos de los mismos. La invención también incluye una composición farmacóutica que comprende una cantidad eficaz del compuesto seleccionado de la invención para usarse en la prevención o tratamiento de adicción a drogas, especialmente abuso o dependencia al alcohol.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITUB2015A002860A ITUB20152860A1 (it) | 2015-08-04 | 2015-08-04 | Selezionata amide dell?acido ?-idrossibutirrico e suoi usi nel trattamento dell?abuso da alcool |
| PCT/EP2016/068517 WO2017021438A1 (en) | 2015-08-04 | 2016-08-03 | SELECTED AMIDE OF γ -HYDROXYBUTYRIC ACID AND USES THEREOF IN THE TREATMENT OF ALCOHOL MISUSE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2018001239A true MX2018001239A (es) | 2018-07-06 |
Family
ID=54542363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018001239A MX2018001239A (es) | 2015-08-04 | 2016-08-03 | Amida seleccionada de acido gamma-hidroxibutirico y usos de la misma en el tratamiento de abuso de alcohol. |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US10336687B2 (es) |
| EP (1) | EP3331853B1 (es) |
| JP (1) | JP6832336B2 (es) |
| KR (1) | KR20180066033A (es) |
| CN (1) | CN108026029B (es) |
| AU (1) | AU2016302869B2 (es) |
| CA (1) | CA2994599C (es) |
| CL (1) | CL2018000282A1 (es) |
| CO (1) | CO2018002428A2 (es) |
| DK (1) | DK3331853T3 (es) |
| EA (1) | EA033769B9 (es) |
| ES (1) | ES2776628T3 (es) |
| GE (1) | GEP20207107B (es) |
| IL (1) | IL257314B (es) |
| IT (1) | ITUB20152860A1 (es) |
| MX (1) | MX2018001239A (es) |
| MY (1) | MY185942A (es) |
| PH (1) | PH12018550008A1 (es) |
| PL (1) | PL3331853T3 (es) |
| PT (1) | PT3331853T (es) |
| UA (1) | UA121994C2 (es) |
| WO (1) | WO2017021438A1 (es) |
| ZA (1) | ZA201801402B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3066711A1 (en) | 2017-07-31 | 2019-02-07 | Novartis Ag | Use of mavoglurant in the reduction of cocaine use or in preventing relapse into cocaine use |
| EP3661501A1 (en) * | 2017-07-31 | 2020-06-10 | Novartis AG | Use of mavoglurant in the reduction of alcohol use or in preventing relapse into alcohol use |
| CN113185403A (zh) * | 2021-07-02 | 2021-07-30 | 山东国邦药业有限公司 | 一种甲醚制备环丙胺中间体环丙甲酸甲酯的方法 |
| WO2023126076A1 (en) * | 2022-01-03 | 2023-07-06 | Laboratorio Farmaceutico C.T. S.R.L. | Medical use of an amide of y-hydroxybutyric acid in the treatment of fragile x syndrome |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1283782B1 (it) * | 1996-08-09 | 1998-04-30 | Ct Lab Farm Srl | Uso di ammidi dell'acido gamma-idrossibutirrico nel trattamento di tossicodipendenze,ed in particolare sell'alcolismo |
-
2015
- 2015-08-04 IT ITUB2015A002860A patent/ITUB20152860A1/it unknown
-
2016
- 2016-08-03 UA UAA201801726A patent/UA121994C2/uk unknown
- 2016-08-03 CA CA2994599A patent/CA2994599C/en active Active
- 2016-08-03 MY MYPI2018700405A patent/MY185942A/en unknown
- 2016-08-03 EP EP16791313.6A patent/EP3331853B1/en active Active
- 2016-08-03 PL PL16791313T patent/PL3331853T3/pl unknown
- 2016-08-03 WO PCT/EP2016/068517 patent/WO2017021438A1/en active Application Filing
- 2016-08-03 AU AU2016302869A patent/AU2016302869B2/en active Active
- 2016-08-03 GE GEAP201614717A patent/GEP20207107B/en unknown
- 2016-08-03 JP JP2018502356A patent/JP6832336B2/ja active Active
- 2016-08-03 EA EA201890419A patent/EA033769B9/ru not_active IP Right Cessation
- 2016-08-03 MX MX2018001239A patent/MX2018001239A/es active IP Right Grant
- 2016-08-03 ES ES16791313T patent/ES2776628T3/es active Active
- 2016-08-03 CN CN201680045364.9A patent/CN108026029B/zh active Active
- 2016-08-03 DK DK16791313.6T patent/DK3331853T3/da active
- 2016-08-03 KR KR1020187006231A patent/KR20180066033A/ko not_active Application Discontinuation
- 2016-08-03 US US15/750,047 patent/US10336687B2/en active Active
- 2016-08-03 PT PT167913136T patent/PT3331853T/pt unknown
-
2018
- 2018-01-31 CL CL2018000282A patent/CL2018000282A1/es unknown
- 2018-02-01 IL IL257314A patent/IL257314B/en active IP Right Grant
- 2018-02-02 PH PH12018550008A patent/PH12018550008A1/en unknown
- 2018-02-28 ZA ZA2018/01402A patent/ZA201801402B/en unknown
- 2018-03-02 CO CONC2018/0002428A patent/CO2018002428A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2994599A1 (en) | 2017-02-09 |
| WO2017021438A1 (en) | 2017-02-09 |
| CN108026029A (zh) | 2018-05-11 |
| EA201890419A1 (ru) | 2018-07-31 |
| PT3331853T (pt) | 2020-02-25 |
| CO2018002428A2 (es) | 2018-07-10 |
| CN108026029B (zh) | 2020-12-04 |
| CL2018000282A1 (es) | 2018-07-13 |
| US10336687B2 (en) | 2019-07-02 |
| ZA201801402B (en) | 2019-01-30 |
| BR112018002245A2 (pt) | 2018-09-18 |
| IL257314B (en) | 2020-04-30 |
| CA2994599C (en) | 2023-08-29 |
| EA033769B1 (ru) | 2019-11-22 |
| EP3331853A1 (en) | 2018-06-13 |
| AU2016302869A1 (en) | 2018-03-15 |
| US20180230086A1 (en) | 2018-08-16 |
| IL257314A (en) | 2018-03-29 |
| EP3331853B1 (en) | 2019-12-11 |
| ITUB20152860A1 (it) | 2017-02-04 |
| MY185942A (en) | 2021-06-14 |
| AU2016302869B2 (en) | 2020-10-22 |
| PL3331853T3 (pl) | 2020-06-15 |
| EA033769B9 (ru) | 2020-04-10 |
| KR20180066033A (ko) | 2018-06-18 |
| JP2018523644A (ja) | 2018-08-23 |
| ES2776628T3 (es) | 2020-07-31 |
| JP6832336B2 (ja) | 2021-02-24 |
| UA121994C2 (uk) | 2020-08-25 |
| DK3331853T3 (da) | 2020-03-16 |
| GEP20207107B (en) | 2020-05-11 |
| PH12018550008A1 (en) | 2018-07-09 |
| GEAP202014717A (en) | 2020-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12017502297A1 (en) | Antibacterial compounds | |
| MX2021000071A (es) | Uso de pridopidina para mejorar la funcion cognitiva y para tratamiento de enfermedad de alzheimer. | |
| MX2021015234A (es) | Composiciones y metodos que comprenden bupropion o compuestos relacionados y dextrometorfano. | |
| PH12015502075A1 (en) | Treatment of cataplexy | |
| PH12017501990A1 (en) | Imidazopyrazinones as pde1 inhibitors | |
| EA036102B9 (ru) | Терапевтические средства с углевод-опосредованной адресной доставкой | |
| PH12016500140A1 (en) | Heterobicycloaryl rorc2 inhibitors and methods of use thereof | |
| PH12018550008A1 (en) | Selected amide of y-hydroxybutyric acid and uses thereof in the treatment of alcohol misuse | |
| MX2015010296A (es) | Tratamiento de formas progresivas de esclerosis multiple con laquinimod. | |
| PH12016501173A1 (en) | Quinazolin-thf-amines as pde1 inhibitors | |
| PH12018500814A1 (en) | Oxadiazaspiro compounds for the treatment of drug abuse and addiction | |
| MX2019001634A (es) | Compuestos amidas, composiciones farmacéuticas de estos y métodos para utilizarlos. | |
| NZ707636A (en) | Ingenol-derived compounds that can be used for treating cancer | |
| GEP20207145B (en) | Combination of trazodone and gabapentin for the treatmen | |
| MX2019001190A (es) | Composicion de liberacion sostenida que comprende tolcapona micronizada. | |
| IN2013MU01223A (es) | ||
| EA201301341A1 (ru) | Фармацевтическая композиция, обладающая панкреопротекторным действием, её применение для профилактики или лечения панкреатита и способ профилактики и лечения панкреатита | |
| IN2013MU01225A (es) | ||
| IN2013MU01222A (es) | ||
| IN2013MU01224A (es) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |